Using an RNAi Signature Assay to Guide the Design of Three-Drug-Conjugated Nanoparticles With Validated Mechanisms, in Vivo Efficacy, and Low Toxicity
Journal of the American Chemical Society - United States
doi 10.1021/jacs.6b06321
Full Text
Open PDFAbstract
Available in full text
Date
September 14, 2016
Authors
Publisher
American Chemical Society (ACS)